But greater use of biosimilars could create significantly more savings. If biosimilars obtained a 75 percent market share, less than the share of these medicines in many European Union nations, the resulting annual savings for the U.S. healthcare system could be nearly $7 billion, based on Winegarden’s analysis.
Not all drugs are created the same. Take generics and biologics: The former is a chemical-based medicine whose manufacture is easily replicated, while the latter is created using biological processes.
But there’s another key difference between those two classes of drugs, and it pertains to the financial state of the healthcare industry and to U.S. taxpayer dollars. Stated plainly, biosimilars have the opportunity to bring significant savings to state Medicaid programs and consumers with commercial insurance. That gives them a leg up over their chemical-based counterparts.
the recycling technology is the result of a partnership between coca-cola, the dutch startup ioniqa technologies and indorama ventures, one of coca-cola’s suppliers of PET plastic. to process the material, ioniqa technologies used a depolymerization technology to break down the PET into its monomers that allow it to be re-produced as a new. it was then sent to an indorama ventures facility to be polymerized into new plastic.
coca-cola has introduced the world’s first bottle created using recycled plastic waste from the ocean. the company has launched an initial edition of 300 bottles made of 25% plastic from the marine waste collected by volunteers during 84 beach cleanups in spain and portugal.
Syndicated columnist Mark Shields and New York Times columnist David Brooks join Judy Woodruff to discuss the week’s political news, including President Trump’s attitude toward Kurds in Syria and stance toward Turkey’s Syria offensive, testimony from the former U.S. ambassador to Ukraine and how the prospect of impeachment affects the race among 2020 Democrats.
Syndicated columnist Mark Shields and Ramesh Ponnuru of The National Review join Judy Woodruff to discuss the week’s political news, including President Trump’s insistence that foreign leaders should investigate the Biden family, how the White House is responding to the subsequent House investigation and the newest fundraising and poll numbers among 2020 Democrats.
Stu Rothenberg of Inside Elections and NPR’s Domenico Montanaro join Judy Woodruff to discuss the latest political news, including how gun policy is factoring into the 2020 presidential campaign, another sexual assault allegation against Justice Brett Kavanaugh, the contest between Sens. Bernie Sanders and Elizabeth Warren for progressive voters and how helpful the Democratic debates are.